Chih Kang Ke
Director/Board Member at TAHO PHARMACEUTICALS LTD
Chih Kang Ke active positions
Companies | Position | Start | End |
---|---|---|---|
TAHO PHARMACEUTICALS LTD | Director/Board Member | - | - |
Independent Dir/Board Member | - | - |
Career history of Chih Kang Ke
Former positions of Chih Kang Ke
Companies | Position | Start | End |
---|---|---|---|
EASYWELL BIOMEDICALS, INC. | Director/Board Member | - | - |
Independent Dir/Board Member | - | - | |
MACHVISION INC. | Director/Board Member | 2010-06-07 | - |
Independent Dir/Board Member | 2010-06-07 | - | |
PHARMADAX INC. | Director/Board Member | - | - |
Global Strategic Investment Management, Inc. | Chief Executive Officer | - | - |
Director of Investments | - | - | |
Private Equity Investor | - | - |
Statistics
International
Taiwan | 6 |
Operational
Director/Board Member | 4 |
Independent Dir/Board Member | 3 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 4 |
Finance | 2 |
Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
MACHVISION INC. | Producer Manufacturing |
EASYWELL BIOMEDICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Global Strategic Investment Management, Inc. | Finance |
PharmaDax Inc.
PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
TAHO Pharmaceuticals Ltd.
TAHO Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Taho Pharmaceuticals Ltd. engages in the research and development of pharmaceutical products. Its Technology Platform products are the Transepithelial Delivery System, Transdermal DDS, Transmucosal SSD, and Bio-Revie. The firm's Research & Development products include medicines for migraine, alzheimer's disease, hyperactivity disorder, and nausea caused by chemotherapy. The company was founded on July 7, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Chih Kang Ke
- Experience